Controlled Release Society
Rui Zhang is an accomplished biopharmaceutical professional currently serving as the Director at Stylus Medicine since April 2023 and as an Industry Representative for the Controlled Release Society since 2020, focusing on gene delivery and gene editing. Previously, Rui held the role of Associate Director at Tessera Therapeutics, where responsibilities included establishing a new functional area and managing a team to develop antibody-conjugated lipid nanoparticles (LNP) with successful preclinical proof of concept. As the first formulation scientist at Spark Therapeutics, Rui built the formulation team from the ground up and contributed significantly to patent filings related to novel DNA-LNPs for gene therapy and immuno-oncology applications. Rui's early career includes a postdoctoral fellowship at the University of Pennsylvania, where 300+ novel LNP formulations were designed and synthesized, and a research assistant position at the University of Missouri. Rui holds a PhD from the University of Missouri-Columbia and a Bachelor's degree from Wuhan Institute of Technology.
This person is not in any teams
This person is not in any offices
Controlled Release Society
The Controlled Release Society (CRS) is the premier society worldwide for delivery science and technology. CRS serves members from more than 50 countries. Two-thirds of CRS membership represents industry and one-third represents academia and government. The field of controlled release encompasses scientific and technical efforts to regulate the spatial and temporal effects of agents in diverse areas including human and animal health as well as non-pharmaceutical areas such as agriculture, cosmetics and consumer products, and the environment. Over the years the mission of CRS has broadened to cover all aspects of delivery science and technology, including increasingly the biological, physiological, preclinical, clinical, and development aspects in addition to maintaining a core focus in the physical science-based aspects such as formulation, processing, synthetic chemistry, and characterization. The controlled release field draws on the expertise of many disciplines including chemistry, chemical engineering, pharmaceutics, physics, materials science, and the biological sciences—biochemistry, biophysics, molecular biology, physiology, cell biology, and medicine to name a few. Today, delivery science and technology is developing into a key multi-disciplinary field with diverse applications and practitioners around the world. The CRS has as a goal to be the premier society world-wide for delivery science and technology.